Method for constructing small salivary gland organs of sjogren syndrome patient
By constructing small salivary gland organoids in patients with Sjögren's syndrome, using three-dimensional scaffolding and single-cell sequencing technology, the problems of genomic instability and phenotypic changes in traditional two-dimensional cell culture are solved, and effective research on the pathological mechanism of salivary glands in patients with Sjögren's syndrome are realized and the possibility of personalized treatment is achieved.
Patent Information
- Application Number
- CN202411916613.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-12-24
- Publication Date
- 2025-03-18
AI Technical Summary
It is difficult to effectively study and understand the pathological mechanism of salivary glands in patients with Sjögren's syndrome. Traditional two-dimensional cell cultures have problems with genomic instability and phenotypic changes.
By constructing an organoid-based disease model, specific steps include isolating adult stem cells from the salivary gland tissue of Sjogren's patients, using laminin-GelMA three-dimensional scaffolds and specific growth factors for cell differentiation and organoid formation, and combining single-cell sequencing technology to analyze the cell diversity of organoids.
The established small salivary gland organoids can faithfully simulate the pathological state of patients' salivary glands, reveal the mechanisms of the immune system destroying salivary gland cells, and the relationship with the clinical symptoms of Sjögren's syndrome, providing new avenues for personalized medicine, drug screening and gene therapy.